⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KNSA News
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
Form 8-K
sec.gov
KNSA
Form 8-K
sec.gov
KNSA
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
globenewswire.com
KNSA
Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026
globenewswire.com
KNSA
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
globenewswire.com
KNSA
REGN
Email Encryption Company Evaluation Report 2025: Cisco Systems, BAE Systems and Fortinet Lead with AI-Driven Cybersecurity, Secure Communications and Cloud-Native Data Protection
globenewswire.com
CSCO
FTNT
AVGO
HPE
KNSA
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
globenewswire.com
KNSA
Form 8-K
sec.gov
KNSA
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
globenewswire.com
KNSA
REGN
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
globenewswire.com
KNSA